Meeting
2019 ASCO Annual Meeting
IMpower150: Analysis of efficacy in patients (pts) with liver metastases (mets).
Authors
Mark A. Socinski
AdventHealth Cancer Institute, Orlando, FL
Mark A. Socinski , Robert M. Jotte , Federico Cappuzzo , Tony S. K. Mok , Howard West , Makoto Nishio , Vassiliki Papadimitrakopoulou , Francisco J Orlandi , Daniil Stroyakovskiy , Christian A. Thomas , Naoyuki Nogami , Fabrice Barlesi , Anthony Lee , Geetha Shankar , Wei Yu , Marcus Ballinger , Ilze Bara , Alan Sandler , Martin Reck
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Clinical Trial Registration Number
NCT02366143
Citation
J Clin Oncol 37, 2019 (suppl; abstr 9012)
DOI
10.1200/JCO.2019.37.15_suppl.9012
Abstract #
9012
Poster Bd #
335
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
J-TAIL-2: A prospective observational study of atezolizumab (atezo) combination therapy in patients (pts) with non-small cell lung cancer (NSCLC) in Japan.
First Author: Yasutaka Watanabe
Poster
2016 ASCO Annual Meeting
Phase III clinical trials of atezolizumab combined with chemotherapy in chemotherapy-naive patients with advanced NSCLC.
First Author: Vassiliki Papadimitrakopoulou
Poster
2022 ASCO Annual Meeting
NEJ043: A phase 2 study of atezolizumab (atezo) plus bevacizumab (bev) plus carboplatin (carbo) plus paclitaxel (pac; ABCP) for previously treated patients with NSCLC harboring EGFR mutations (EGFRm).
First Author: Naoki Furuya
Poster
2020 ASCO Virtual Scientific Program
IMpower150: Exploratory analysis of brain metastases development.
First Author: Federico Cappuzzo